Correlation Engine 2.0
Clear Search sequence regions


  • and disease (2)
  • axial (5)
  • back pain (2)
  • bath (8)
  • cognitive (1)
  • cohort (1)
  • diagnosis (2)
  • female (1)
  • HLA B27 (16)
  • hla b27 antigen (2)
  • hla- antigen (1)
  • humans (1)
  • mild pain (2)
  • patients (3)
  • risk factors (1)
  • Sizes of these terms reflect their relevance to your search.

    HLA-B27 is associated with increased susceptibility and disease activity of ankylosing spondylitis, but the effect of HLA-B27 on the activity of the broader category now called axial spondyloarthritis (AxSpA) is apparently the opposite. A modified Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was used to assess disease activity among 3435 patients with spondyloarthritis (SpA) who participated in a survey designed to assess the effect of their disease and its treatment on the susceptibility and severity of Covid-19. Chi square testing was used to compare BASDAI scores between HLA-B27 positive and negative subjects. 2836 survey respondents were HLA B27 positive. The average BASDAI for the HLA-B27 negative cohort was 4.92 compared to 4.34 for the HLA-B27 positive subjects. Based on linear regression, a subject's sex could not fully account for the differing BASDAI score in HLA-B27 negative subjects compared to those who are HLA-B27 positive. The difference between B27 positive and negative subjects was skewed by those with a BASDAI score of one or two. HLA-B27 positive subjects were more than twice as likely to have a BASDAI score of 1 compared to HLA B27 negative subjects and about 60% more likely to have a BASDAI score of 2 (pā€‰<ā€‰0.0001). HLA-B27 positive subjects have less active spondyloarthritis compared to HLA-B27 negative subjects as measured by a BASDAI score. Our data indicate that patients with mild back pain and a diagnosis of AxSpA are disproportionately HLA-B27 positive. The HLA-B27 test facilitates the diagnosis of axial spondyloarthritis such that patients from a community survey with mild back pain may be disproportionately diagnosed as having AxSpA if they are HLA-B27 positive. The test result likely introduces a cognitive bias into medical decision making and could explain our observations.

    Citation

    James T Rosenbaum, Michael H Weisman, Hedley Hamilton, Cassie Shafer, Elin Aslanyan, Richard A Howard, Kimberly Ogle, John D Reveille, Kevin L Winthrop, Dongseok Choi. HLA-B27 is associated with reduced disease activity in axial spondyloarthritis. Scientific reports. 2021 Jun 10;11(1):12331

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34112886

    View Full Text